Previous research has shown that overexpression of CXCR3 in cancer cells (e.g., breast cancer, gastric cancer cells) can promote cancer proliferation, migration, metastasis, and angiogenesis leading to poor clinical prognosis (Zhou et al., 2016; Bronger et al., 2017). Here, CXCR3 is linked to gastric cancer.